Page 9 - Stan Erck News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Fourth Covid-19 vaccine set to be approved in UK - how does Novavax work? (PA) A fourth coronavirus vaccine could be approved in the UK within a matter of weeks as late-stage trials suggested it was 89% effective in preventing the virus. The UK has secured 60 million doses of the Novavax jab – to be produced on Teesside – which is believed to offer protection against the new UK and South African variants. It was shown to be 89.3% effective at preventing coronavirus in participants in its Phase 3 clinical trial in the UK, which involved more than 15,000 people aged between 18-84, of ...

Fourth Covid-19 vaccine set to be approved in UK - how does Novavax work? (PA) A fourth coronavirus vaccine could be approved in the UK within a matter of weeks as late-stage trials suggested it was 89% effective in preventing the virus. The UK has secured 60 million doses of the Novavax jab – to be produced on Teesside – which is believed to offer protection against the new UK and South African variants. It was shown to be 89.3% effective at preventing coronavirus in participants in its Phase 3 clinical trial in the UK, which involved more than 15,000 people aged between 18-84, of ...

Fourth Covid-19 vaccine set to be approved in UK - how does Novavax work? (PA) A fourth coronavirus vaccine could be approved in the UK within a matter of weeks as late-stage trials suggested it was 89% effective in preventing the virus. The UK has secured 60 million doses of the Novavax jab – to be produced on Teesside – which is believed to offer protection against the new UK and South African variants. It was shown to be 89.3% effective at preventing coronavirus in participants in its Phase 3 clinical trial in the UK, which involved more than 15,000 people aged between 18-84, of ...

Covid-19: Novavax vaccine shows 89% efficacy in UK trials A new coronavirus vaccine has been shown to be 89.3% effective in large-scale UK trials. The Novavax jab is the first to show it is effective against the new variant of the virus discovered in the UK, the BBC’s medical editor Fergus Walsh said. The PM welcomed the “good news” and said the UK’s medicines regulator would now assess the vaccine.   The UK has secured 60 million doses of the jab, which will be made in Stockton-on-Tees. The doses are expected to be delivered in the second half of this year, if approved for use by th...

Health Secretary Matt Hancock said the NHS stands ready to roll out the vaccine if it is approved.